Article
images
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
OKYO Pharma announces positive results from phase 2 trial of urcosimod for neuropathic corneal pain
3 Things You Should Know About Interventional Glaucoma Comanagement
Harrow enters into agreement with Samsung Bioepis for commercial rights to its ophthalmology biosimilar portfolio
Patient-Centered Treatment Strategies in the Management of nAMD and DME
FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap
FDA grants fast track designation to Sanofi’s SAR446597